Catecholamines Abrogate Antimitogenic Effects of 2-Hydroxyestradiol on Human Aortic Vascular Smooth Muscle Cells
- 1 November 2001
- journal article
- other
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 21 (11) , 1745-1750
Abstract
Catechol- O -methyltransferase (COMT)-mediated methylation of 2-hydroxyestradiol (endogenous estradiol metabolite) to 2-methoxyestradiol (angiogenesis inhibitor) may be responsible for the antimitogenic effects of 2-hydroxyestradiol on vascular smooth muscle cells (VSMCs). Catecholamines are also substrates for COMT, and increased levels of catecholamines are associated with vasoocclusive disorders. We hypothesize that catecholamines may abrogate the vasoprotective effects of 2-hydroxyestradiol by competing for COMT and inhibiting 2-methoxyestradiol formation. To test this hypothesis, we investigated the antimitogenic effects of 0.001 to 0.1 μmol/L of 2-hydroxyestradiol on human aortic VSMC proliferation (cell number and DNA synthesis), collagen synthesis, and migration in the presence and absence of catecholamines. Norepinephrine, epinephrine, and isoproterenol concentration-dependently abrogated the inhibitory effects of 2-hydroxyestradiol on cell number, DNA synthesis, collagen synthesis, and cell migration. These modulatory/attenuating effects of catecholamines were not abrogated in the presence of the α- and β-adrenergic receptor antagonists, phentolamine mesylate and propranolol, respectively. In contrast to 2-hydroxyestradiol, the antimitogenic effects of 2-methoxyestradiol (0.1 μmol/L) were not attenuated by isoproterenol (1 μmol/L) or quercetin (competitive inhibitor of COMT, 10 μmol/L). Norepinephrine, epinephrine, and isoproterenol concentration-dependently (10 to 500 μmol/L) inhibited the metabolism of 2-hydroxyestradiol (0.25 to 2 μmol/L) to 2-methoxyestradiol, and the potency of the catecholamines to reverse 2-hydroxyestradiol-induced inhibition of VSMC proliferation, collagen synthesis, and migration was correlated with their ability to inhibit 2-methoxyestradiol formation. Our findings suggest that catecholamines within the vasculature may abrogate the anti-vaso-occlusive effects of estradiol and 2-hydroxyestradiol by blocking 2-methoxyestradiol formation.Keywords
This publication has 12 references indexed in Scilit:
- Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanismsAmerican Journal of Physiology-Renal Physiology, 2001
- Increased 2-Methoxyestradiol Production in Human Coronary Versus Aortic Vascular CellsHypertension, 2001
- Methoxyestradiols Mediate the Antimitogenic Effects of Estradiol on Vascular Smooth Muscle Cells via Estrogen Receptor-Independent MechanismsBiochemical and Biophysical Research Communications, 2000
- Vascular effects of environmental oestrogens: implications for reproductive and vascular healthHuman Reproduction Update, 2000
- Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female miceProceedings of the National Academy of Sciences of the United States of America, 1999
- 17β-Estradiol, Its Metabolites, and Progesterone Inhibit Cardiac Fibroblast GrowthHypertension, 1998
- Nitric Oxide Modulates Basal and Endothelin-induced Coronary Artery Vascular Smooth Muscle Cell Proliferation and Collagen LevelsJournal of Molecular and Cellular Cardiology, 1997
- Estrogen inhibits the vascular injury response in estrogen receptor α-deficient miceNature Medicine, 1997
- Formation, metabolism and physiologic importance of catecholestrogensAmerican Journal of Obstetrics and Gynecology, 1990
- A possible role of catecholamines in atherogenesis and subsequent complications of atherosclerosisExperimental pathology, 1987